Evidence map›Paper›PMID 24506537›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2014

TGFBR1 is required for mouse myometrial development.

Yang Gao, Kayla J Bayless, Qinglei Li

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Rediscovering theeLife · 2025
    Article
  3. Rediscovering thebioRxiv : the preprint server for biology · 2024
    Article
  4. Single-cell transcriptomic profiling of the neonatal oviduct and uterus reveals new insights into upper Müllerian duct regionalization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. TGFβ superfamily signaling and uterine decidualization.Reproductive biology and endocrinology : RB&E · 2017
    Review
  13. The TGF-β Family in the Reproductive Tract.Cold Spring Harbor perspectives in biology · 2017
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Transforming growth factor β signaling in uterine development and function.Journal of animal science and biotechnology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yang GaoDepartment of Veterinary Integrative Biosciences (Y.G., Q.L.), College of Veterinary Medicine and Biomedical Sciences, and Department of Molecular and Cellular Medicine (K.J.B.), Texas A&M Health Science Center, Texas A&M University, College Station, Texas 77843.
Kayla J Bayless
Qinglei Li
Texas A&M Health Science Center · USTexas A&M Health Science Center · US

Funding

TGF-BETA Signaling in Myometrial Development and FunctionR21HD073756 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI LI, QINGLEI · 2012 to 2013
$396k
NICHD NIH HHS R21 HD073756NICHD NIH HHS R21HD073756
6 · The paper itself

Abstract

The smooth muscle layer of the uterus (ie, myometrium) is critical for a successful pregnancy and labor. We have shown that the conditional deletion of TGFβ type 1 receptor (TGFBR1) in the female reproductive tract leads to remarkable smooth muscle defects. This study was aimed at defining the cellular and molecular basis of the myometrial defects. We found that TGFBR1 is required for myometrial configuration and formation during early postnatal uterine development. Despite the well-established role of TGFβ signaling in vascular smooth muscle cell differentiation, the majority of smooth muscle genes were expressed in Tgfbr1 conditional knockout (cKO) uteri at similar levels as controls during postnatal uterine development, coinciding with the presence but abnormal distribution of proteins for select smooth muscle markers. Importantly, the uteri of these mice had impaired synthesis of key extracellular matrix proteins and dysregulated expression of platelet-derived growth factors. Furthermore, platelet-derived growth factors induced the migration of uterine stromal cells from both control and Tgfbr1 cKO mice in vitro. Our results suggest that the myometrial defects in Tgfbr1 cKO mice may not directly arise from an intrinsic deficiency in uterine smooth muscle cell differentiation but are linked to the impaired production of key extracellular matrix components and abnormal uterine cell migration during a critical time window of postnatal uterine development. These findings will potentially aid in the design of novel therapies for reproductive disorders associated with myometrial defects.

Indexed as

AnimalsCell MovementCells, CulturedExtracellular MatrixFemaleGene ExpressionMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMyocytes, Smooth MuscleMyometriumPlatelet-Derived Growth FactorProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IPlatelet-Derived Growth FactorProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouseTransforming Growth Factor beta

Identifiers

PMID24506537
PMCPMC3938542
OpenAlexW2034680394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.